Previewing the Year Ahead in Rheumatology

As the year winds down and a new year is about to begin, looking back sometimes forces us to look ahead. Last month’s Convergence 2023 offered an opportunity to do just that: Look Ahead! We’ve invited the two speakers from the “The Clinical Year in Preview” session, Joan Bathon, MD and Jill Buyon, MD to discuss with us the latest abstracts that are expected to make the biggest waves in the coming year, as they relate to Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE). We discuss a variety of abstracts that include the use of AI, steroid use, hydroxychloroquine dosing, preventing the development of RA in lupus, pregnancy in lupus dosing for methotrexate and much, much more.